If you’re anything like me, your pet’s comfort is of the utmost importance. A recent Phys.org article noted the FDA’s approval of the first monoclonal antibody treatment for feline arthritis. The drug is called Solensia, aka frunevetmab, and it’s a cat-specific monoclonal antibody that binds to a protein associated with pain, blocking the signal from reaching the brain. Solensia is marketed by Zoetis, and is only available via prescriptions from licensed veterinarians.
FDA Approves Osteoarthritis Pain Treatment for Cats
The prescription-only injection blocks pain signals from reaching the brain in cats.
Jan 17, 2022
Recommended
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
